Concepedia

Timothy G. Whitsett

TG

26

Publications

1.6K

Citations

19

H-Index

2006

Active since

Affiliations

Translational Genomics Research Institute(Current)

St. Joseph's Hospital and Medical Center

University of Maryland, Baltimore

University of California San Diego

The University of Texas MD Anderson Cancer Center

Timothy G. Whitsett is an author at Translational Genomics Research Institute specializing in medicine, pathology, and cell biology.

Top concepts

MedicinePathologyCell BiologyTumor BiologyCancer ResearchCancer BiologyCell SignalingRadiation OncologyOncologyImmunology

Publications per year

2006–2024

26

Publications

26

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

Siyuan Zheng, Andrew D. Cherniack, Ninad Dewal et al. · Cancer Cell · 2016 · 645 citations · Full text

Pathology, Cancer Genomics, Adrenal Disease +3

Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats.

Timothy G. Whitsett, Mark Carpenter, Coral A. Lamartiniere · Journal of Carcinogenesis · 2006 · 136 citations · Full text

Breast Oncology, Chemoprevention Strategy, Pathology +19

RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s disease

David W. Craig, Elizabeth Hutchins, Ivo Violich et al. · Nature Aging · 2021 · 80 citations

Neurodegenerative Diseases, Autoimmune Disease, Disease Mechanism +9

Extracellular microRNAs in blood differentiate between ischaemic and haemorrhagic stroke subtypes

M. Yashar S. Kalani, Eric Alsop, Bessie Meechoovet et al. · Journal of Extracellular Vesicles · 2020 · 70 citations · Full text

CRL4A-FBXW5–mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth

Tai Young Kim, Sarah A. Jackson, Yue Xiong et al. · Proceedings of the National Academy of Sciences · 2013 · 62 citations · Full text

Dlc1 Mrna, Crl4a-fbxw5–mediated Degradation, Cancer Biology +21

Rows per page

1–5 of 26